High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myelomaBruno Paiva, Jesús F. San Miguel, Norma C. Gutiérrez et al.|Blood|2011Cited by 304
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose TherapyGema Mateo, Jesús F. San Miguel, María-Ángeles Montalbán et al.|Journal of Clinical Oncology|2008Cited by 210
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenanceMaría‐Victoria Mateos, Jesús F. San Miguel, Norma C. Gutiérrez et al.|Blood|2011Cited by 58
Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study),Elena Fernandez Redondo, Juan José Lahuerta, María Luisa Martín et al.|Blood|2011Cited by 1